Loading...
Controlled delivery of ciprofloxacin using zirconium-based MOFs and poly-caprolactone composites
Aden, S.F. Mahmoud, L.A.M. Ivanovska, E.H. Terry, L.R. Ting, V.P.
Aden, S.F.
Mahmoud, L.A.M.
Ivanovska, E.H.
Terry, L.R.
Ting, V.P.
Publication Date
2023-10
End of Embargo
Supervisor
Rights
© 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2023-08-28
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
With antimicrobial resistance (AMR) increasing at an alarming rate, there is a need to develop better antibiotic delivery platforms at the point of need, to reduce over-exposure to antibiotics that are delivered systemically. Recent studies have suggested the use of metal-organic frameworks (MOFs) as potential vehicles for controlled and efficient delivery of various active pharmaceutical ingredients (APIs). Development of MOF-polymer composite materials can assist in the development of medical devices that can deliver APIs to local sites in a targeted approach. This study reports the encapsulation of a widely used antibiotic - ciprofloxacin (CIP) - into two Zr-based MOFs (UiO-66 and UiO-66-NH2) and their subsequent integration into a biodegradable polymer; polycaprolactone (PCL), via solvent casting, to obtain a PCL-MOF composite membrane. The MOFs and PCL-MOF composites were characterised by Fourier-transformed infrared (FT-IR) spectroscopy, powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA) and scanning electron microscopy (SEM). The results demonstrated that the structural integrity of the pristine MOFs was maintained after drug loading and incorporation into the PCL membranes. The ciprofloxacin release was studied using ultraviolet–visible (UV–Vis) spectroscopy, and the results showed that the PCL-MOF composites had a more controlled drug release profile compared to the MOF alone, when monitored for seven days in phosphate buffered saline (PBS) and accelerated ageing (AA) release media. In addition, release studies showed pH-dependence with faster release of ciprofloxacin at both acidic and basic conditions. Antimicrobial assay showed excellent efficacy for both CIP-loaded MOFs and their PCL composites against S. aureus and E. coli, a Gram-negative and Gram-positive bacterium, respectively, with inhibition zone as high as >50 mm against E. coli for UiO-66-NH2-CIP, indicating their potential applications in purpose-specific medical devices.
Version
Published version
Citation
Aden SF, Mahmoud LAM, Ivanovska EH et al (2023) Controlled delivery of ciprofloxacin using zirconium-based MOFs and poly-caprolactone composites. Journal of Drug Delivery Science and Technology. 88: 104894.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article